Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Gynecol Minim Invasive Ther ; 11(4): 215-220, 2022.
Article in English | MEDLINE | ID: mdl-36660330

ABSTRACT

Objectives: To evaluate the feasibility and safety of laparoscopic surgery for large ovarian masses with benign features. Materials and Methods: Women who underwent laparoscopic surgery for an ovarian mass with benign features between 2017 and 2019 at a tertiary referral center were included in the retrospective study. Based on the size of the ovarian mass, the women were divided into the case and control groups of ≥10 cm and <10 cm, respectively. Clinical characteristics, operative findings, histopathological results, and complication rates of the groups were compared. Results: A total of 260 women, 64 women with large masses and 196 with small masses were included in the study. The operation time, intraoperative cyst rupture rate, complication rate, and hospital stay were similar in the case and control groups (P > 0.05). The cyst aspiration rate (29.7% vs. 5.1%, P < 0.001) and the unexpected malignancy rate (7.8% vs. 0.0% P = 0.001) were significantly higher in the case group than in the control group. Conclusion: Laparoscopic surgery was found feasible for the treatment of women with large ovarian masses. However, a higher unexpected malignancy rate requires the careful patient selection and appropriate counseling preoperatively in these cases.

2.
Eur J Contracept Reprod Health Care ; 26(6): 507-512, 2021 Dec.
Article in English | MEDLINE | ID: mdl-33855927

ABSTRACT

OBJECTIVES: The study aimed to determine the awareness of emergency contraception (EC) and knowledge of its use as well as the unplanned pregnancy rate among women in the immediate postpartum period in Ankara, Turkey's second largest city. METHODS: Interviews were carried out among 1955 women on their first or second day postpartum. The interview was based on a questionnaire containing 19 questions covering participants' awareness and experience of using EC as well as their future approach to its use. RESULTS: The rate of unplanned pregnancy was 18.2% and the rate of EC awareness was 26.0%; 89.4% of those who were aware of EC knew how to use it correctly. In the multivariate regression analysis, employment, household income and level of education were independently associated with EC awareness; gravidity, household income, level of education and number of abortions were independently associated with unplanned pregnancy. Awareness of EC increased significantly (p < .05) with age, household income and educational level; knowledge about the correct use of EC increased with age and educational level (p < .05). CONCLUSION: EC awareness among the study population was low and was related to household income and educational level. Household income, educational level and gravidity were the most important factors associated with unplanned pregnancy. Governments must therefore establish appropriate health policies and provide contraceptive education to women from adolescence onwards.


Subject(s)
Contraception, Postcoital , Adolescent , Contraception , Female , Health Knowledge, Attitudes, Practice , Humans , Postpartum Period , Pregnancy , Pregnancy, Unplanned , Surveys and Questionnaires
4.
Obstet Gynecol Sci ; 62(4): 273-279, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31338345

ABSTRACT

OBJECTIVE: To investigate the correlation between sonographic, hysteroscopic, and pathological findings in postmenopausal asymptomatic patients with sonographically thickened endometrium. METHODS: The records of postmenopausal patients who attended the Menopause Outpatient Clinic of a tertiary women's hospital in Ankara, Turkey between January 1, 2012 and December 15, 2013 were retrieved. A total of 266 postmenopausal women without vaginal bleeding underwent hysteroscopic evaluation and endometrial sampling. Patients whose pathological records indicated an endometrial thickness equal to or greater than 6 mm (double layer) on transvaginal ultrasonography without any symptoms were included in the study. RESULTS: The most frequently detected focal intrauterine lesions in asymptomatic women were endometrial polyps, which were diagnosed in 168 (63.1%) cases. Twenty-four (9%) patients were diagnosed as having simple hyperplasia, 4 (1%) atypical hyperplasia, and 8 (3%) endometrial adenocarcinoma. Two of the patients with adenocarcinoma were diagnosed based on endometrial polyps, and 6 cases showed endometrial hyperplasia on hysteroscopy, while histological examination showed endometrial carcinoma. CONCLUSION: We suggest 10.5 mm as the cutoff value for endometrial thickness and recommend hysteroscopy following dilatation and curettage to increase diagnostic efficacy and provide definitive treatment in asymptomatic postmenopausal women with thickened endometrium.

6.
Taiwan J Obstet Gynecol ; 55(2): 251-7, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27125410

ABSTRACT

OBJECTIVE: Endometriosis is a chronic inflammatory disease pathologically defined as the presence of endometrial-like tissue outside the uterine cavity. It is one of the most important diseases affecting women of reproductive age. The process of endometriotic implant growth is mediated by many complex interactions of immunologic, hormonal, genetic, and environmental mediators. Vitamin C (ascorbic acid), besides playing a role in preventing invasion and metastasis, is an antioxidant having anti-inflammatory and -angiogenic effects. In this study, we aimed to investigate the effect of vitamin C on the prevention and regression of endometriotic implants in a rat model of endometriosis. MATERIALS AND METHODS: This was a prospective, comparative, experimental animal study. After endometriotic implants were induced simultaneously, rats were divided into three groups. Group A was given 500 mg/kg of intravenous vitamin C every 2 days, starting immediately after implantation (n = 11). All rats had a second operation 21 days after the initial one and had the lesion volumes measured. Group B was given 500 mg/kg of intravenous vitamin C every 2 days, starting 21 days after this operation (n = 11). All rats were sacrificed 21 days after the third operation. Implant volume, weight measurements, and histopathological evaluation of the lesions were carried out. Group A received vitamin C throughout the study, while Group C (n = 11) was not given any medication. The findings in the three groups were compared. RESULTS: At the second laparotomy after the induction, Group A had the smallest implant volume with a statistically significant difference compared to Group B (p = 0.012). The end-of-study volumes of endometriotic implants of group B were significantly smaller than the first volumes (p < 0.05). CONCLUSION: Intravenous vitamin C treatment might have a suppressive effect on the prevention of endometriotic implant induction and regression of endometriotic implant volumes.


Subject(s)
Antioxidants/therapeutic use , Ascorbic Acid/therapeutic use , Endometriosis/drug therapy , Endometriosis/prevention & control , Animals , Disease Models, Animal , Endometriosis/pathology , Female , Prospective Studies , Rats , Rats, Wistar
7.
Exp Ther Med ; 9(5): 1813-1818, 2015 May.
Article in English | MEDLINE | ID: mdl-26136898

ABSTRACT

The aim of this study was to investigate the possible therapeutic effects of Doxycycline (Dox) on endometriotic lesions in an experimental rat model. Thirty-seven female Wistar albino rats with surgically induced endometriosis were randomized and divided into four groups. The rats were administered 5 mg/kg/day oral Dox in Group 1 (low-dose Dox group, n=9), 20 mg/kg/day oral Dox in Group 2 (high-dose Dox group, n=10) and 1 mg/kg single dose, subcutaneous leuprolide acetate in Group 3 (leuprolide acetate group, n=9). The rats in Group 4 (control group, n=9) were given no medication. The rats received medication for three weeks and were then sacrificed to evaluate the morphological and histological features of the implants. Matrix metalloproteinase (MMP)-9 immunoreactivity of the implants was also evaluated. The size of the endometriotic implants decreased in Groups 1-3 but statistically significant differences were not observed among the groups. The mean surface area of the endometriotic implants decreased from 69.3±30.8 to 52.1±27.0 mm² in Group 1 (P>0.05), from 60.2±18.9 to 38.6±28.7 mm² in Group 2 (P>0.05) and from 58.1±33.1 to 26±9.0 mm² in Group 3 (P=0.03). The epithelial MMP-9 immunohistochemical score was significantly higher in Group 1 and lower in Group 3 when compared with the control group (Group 4) (P=0.042 and P=0.014, respectively). When the stromal MMP-9 immunohistochemical and histopathological scores of the endometriotic implants were compared, no statistically significant differences were found among the groups. Although there was no statistically significant difference, Dox reduced the endometriotic implant area in the rat endometriosis model. Further studies are required to investigate the potential efficacy of Dox in endometriosis due to its widespread use and tolerability.

8.
J Obstet Gynaecol Res ; 40(6): 1573-7, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24888918

ABSTRACT

AIM: To determine factors associated with face presentation of term fetuses delivered. METHODS: Of 34,480 consecutive, term deliveries of uncomplicated pregnancies within a 3-year period, all live, singleton term fetuses with cephalic presentation in which no lethal anomalies occurred that were diagnosed with a face presentation were studied. Factors that may have contributed to the etiology of the presentation including age, parity and fetal size were evaluated. Ultrasonographic evaluation was recorded. RESULTS: Fifty cases were diagnosed with an incidence of 0.14%. Parity was not associated with face presentation. Birthweight of 4000 g or more indicated an increased risk of approximately 2.9-fold, whereas fetuses weighing 3000-3499 g were found to have a relatively decreased risk of face presentation when compared with the general obstetrics group (P = 0.015 and 0.001, risk ratio = 2.948 and 0.450, respectively). With physical examination, only 70% were diagnosed correctly. CONCLUSION: Face presentation is a rare event and birthweight more than 4000 g was found to be associated with face presentation. Parity is not an associated factor.


Subject(s)
Labor Presentation , Adolescent , Adult , Face , Female , Humans , Pregnancy , Retrospective Studies , Term Birth , Young Adult
9.
Int J Gynecol Cancer ; 24(3): 600-7, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24557439

ABSTRACT

OBJECTIVE: The objective of this study was to examine perioperative outcomes, including complication rates, of conventional laparoscopy (CL) versus robotic-assisted laparoscopy (RALS) in the evaluation and management of early, advanced, and recurrent ovarian, fallopian tube, and peritoneal cancer. METHODS: This is a retrospective analysis of a prospectively maintained database of surgery performed from July 2008 to December 2012. Sixty-three women had 83 surgeries performed; 22 surgeries for early-stage disease (International Federation of Gynecology and Obstetrics stage I) and 61 for advanced and/or recurrent disease. RESULTS: Of the 22 for early stage, 10 were CL, 9 were RALS, and 3 were laparoscopy converted to laparotomy (LP). There was no significant difference between CL and RALS in estimated blood loss (EBL, P = 0.27) or length of stay (LOS, P = 0.43); however, both had significantly less EBL (P = 0.03 and 0.03, respectively) and LOS (P = 0.03 and 0.03) than LP. There was no difference in OR time among the groups (P = 0.79). One patient (33%) had an intraoperative complication in LP. One patient (10%) had a postoperative complication in CL, 2 (22%) in RALS, and 1 (33%) in LP, with no significant difference (P = 0.61).Among the 42 patients with advanced/recurrent disease, 61 surgeries were performed: 14 diagnostic procedures and 47 cytoreductive surgeries. Of the 47, there was no difference in operating room time (P = 0.10). There was no difference in EBL or LOS between CL and RALS (P = 0.82, P = 0.87); however, both were less in CL (P < 0.001 and P = 0.02) and RALS (P = 0.01 and P = 0.02) compared with LP. There were 5 (63%) intraoperative transfusions in LP and none in CL or RALS. When including all surgeries for advanced/recurrent disease, there was 1 intraoperative complication (12%) in LP. There was no difference in postoperative complications between groups (P = 0.89); 8 patients (19%) had postoperative complications in CL, 2 (18%) in RALS, and 2 (25%) in LP. Overall, there were no grade 4 or 5 complications and no perioperative or intraoperative deaths. CONCLUSIONS: In our experience, perioperative outcomes are comparable between CL and RALS in both early and advanced/recurrent disease and not inferior to laparotomy, making CL and RALS an acceptable approach in selected patients.


Subject(s)
Fallopian Tube Neoplasms/surgery , Laparoscopy/methods , Ovarian Neoplasms/surgery , Peritoneal Neoplasms/surgery , Postoperative Complications , Adult , Aged , Aged, 80 and over , Female , Humans , Middle Aged , Perioperative Period , Retrospective Studies , Robotics , Treatment Outcome
10.
J Matern Fetal Neonatal Med ; 26(11): 1128-31, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23350686

ABSTRACT

OBJECTIVE: To evaluate short-term effects of closure versus non-closure of the parietal peritoneum at caesarean section. METHODS: A randomized controlled study of women undergoing caesarean section was conducted at the obstetrics department of a research and education hospital between October 2010 and May 2011. Patients were randomly assigned to have closure of parietal peritoneal layer (Group I, n = 55), and non-closure of parietal peritoneal layer (Control, Group II, n = 55). Intra-operative and post-operative outcomes were compared between the groups. RESULTS: Groups were similar for baseline characteristics. Although there was statistically significant difference between Group 1 and Group 2 in terms of time to oral intake and mobilization time [12 (8-12) versus 8 (8-10) h; p < 0.001; 12 (8-12) versus 8 (8-10) h; p < 0.001]; the other variables, such as drop in hemoglobin concentration, estimate of blood loss, intra-operative additional sutures, operating time and time to passage of flatus [1.13 ± 0.86 versus 1.41 ± 0.82 g/dL; 487.9 ± 217.01 versus 544.87 ± 237.64 mL; 0 (0-1) versus 0 (0-1); 30.8 ± 7.63 versus 31.6 ± 10.38 h; 18.2 ± 6.04 versus 18.2 ± 4.23 h, p > 0.05] were not statistically different between Group 1 and Group 2. CONCLUSIONS: Closure of the parietal peritoneum has no benefit over non-closure of parietal peritoneum and non-closure is associated with rapid post-operative recovery.


Subject(s)
Abdominal Wound Closure Techniques , Cesarean Section/methods , Peritoneum/surgery , Abdominal Wound Closure Techniques/statistics & numerical data , Adult , Blood Loss, Surgical/statistics & numerical data , Cesarean Section/statistics & numerical data , Feasibility Studies , Female , Humans , Pain, Postoperative/epidemiology , Postoperative Complications/epidemiology , Pregnancy , Suture Techniques/statistics & numerical data , Young Adult
11.
Early Hum Dev ; 89(3): 191-4, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23103026

ABSTRACT

AIM: The present study aimed to compare Troponin T (Tp T) levels of infants born with meconium stained amniotic fluid (MSAF) to those with clear amniotic fluid. STUDY DESIGN: Case-control study SUBJECTS: Thirty-five women who had delivery complicated by MSAF between 37 and 41weeks of gestation were defined as the study group and women with healthy uncomplicated pregnancies with clear amniotic fluid who were matched for age, parity, and gestational age were defined as the control group. OUTCOME MEASURES: Cord blood Tp T level, gas analysis and neonatal outcomes were compared between groups. RESULTS: Tp T levels of the study and control groups were 0.026±0.013ng/ml and 0.031±0.016ng/ml, respectively. The difference was not statistically significant (p=0.132). On the other hand, the study group had a statistically lower HCO(3) level (21.80 vs 23.60mmol/l ) and higher rate of base deficit (4.85 vs 3.25mmol/l) than the control group. CONCLUSION: The presence of meconium during labor is not related to occult myocardial injury in low-risk term pregnancies.


Subject(s)
Amniotic Fluid/chemistry , Biomarkers/blood , Cardiomyopathies/diagnosis , Fetal Blood/chemistry , Meconium/chemistry , Troponin T/blood , Bicarbonates/blood , Cardiomyopathies/blood , Case-Control Studies , Female , Heart Rate, Fetal , Humans , Immunoassay , Pregnancy , Statistics, Nonparametric
12.
J Matern Fetal Neonatal Med ; 26(3): 233-6, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23030834

ABSTRACT

OBJECTIVE: The aim of this study was to compare cord blood S100B levels and cord blood gas parameters of term infants with meconium-stained amniotic fluid (MSAF) to those infants with clear amniotic fluid. METHODS: Term pregnant women at an active phase of labor and having MSAF were defined as the study group (n = 35) and pregnant women with clear amniotic fluid, and matched for age, parity, and gestational age were defined as the control group (n = 35). Cord blood S100B levels and gas parameters were measured. RESULTS: LogS100B values of study and control groups were 2.40 ± 0.21 and 2.43 ± 0.29 pg/ml, respectively. The difference was not statistically significant (p = 0.675). LogS100B levels slightly increased as meconium thickened. (2.32 ± 0.16, 2.41 ± 0.17, and 2.44 ± 0.28 pg/ml, respectively). However, no difference was found between groups (p = 0.438). Moreover, the study group had a statistically lower HCO(3) level (21.80 vs 23.60 mmol/l) and a higher rate of base deficit (4.85 vs 3.25 mmol/l) than the control group. However, median HCO(3) and base deficit values were within normal limits in both groups. CONCLUSION: The present study showed that cord blood S100B levels of infants born through MSAF were not different from those with clear amniotic fluid. This finding suggests that MSAF, regardless of its thickness, may not be related to brain damage in low risk term pregnancies.


Subject(s)
Amniotic Fluid/metabolism , Fetal Blood/chemistry , Meconium/metabolism , Nerve Growth Factors/blood , S100 Proteins/blood , Term Birth/blood , Adult , Bicarbonates/analysis , Bicarbonates/blood , Blood Gas Analysis , Case-Control Studies , Female , Fetal Blood/metabolism , Humans , Infant, Newborn , Meconium Aspiration Syndrome/blood , Meconium Aspiration Syndrome/diagnosis , Meconium Aspiration Syndrome/metabolism , Nerve Growth Factors/analysis , Pregnancy , Risk Factors , S100 Calcium Binding Protein beta Subunit , S100 Proteins/analysis , Term Birth/physiology , Young Adult
13.
Arch Gynecol Obstet ; 286(5): 1131-4, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22744849

ABSTRACT

PURPOSE: To determine the incidence, indications and the risk factors of emergency peripartum hysterectomy (EPH). METHODS: We analyzed retrospectively 30 cases of emergency peripartum hysterectomy performed at the Obstetrics Department of a tertiary, research and education hospital between the years of 2006 and 2010. Demographic, medical and clinical data of the patients were recorded. Data stored were expressed as mean ± standard deviation. RESULTS: There were 30 cases of EPH among 82,363 deliveries. The overall incidence of EPH was 0.364 per 1,000 deliveries from 2006 to 2010. Nine hysterectomies were performed after vaginal delivery (0.16/1,000 vaginal deliveries) and the remaining 21 hysterectomies were performed after cesarean section (0.78/1,000 cesarean sections). Two cases (6.7 %) were performed as subtotal and remaining 28 cases (93.3 %) were performed as total hysterectomy. Indications of EPH were uterine atony (43.3 %, 13/30), placenta accreta (40.0 %, 12/30) and uterine rupture (16.7 %, 5/30). All patients [7/7 (100 %)] with placenta previa and 11 of 12 patients (91.7 %) with placenta accreta had previously cesarean sections. There were two maternal deaths due to coagulopathy and pulmonary embolism. Two stillbirths (6.6 %) and 2 early neonatal deaths (6.6 %) were recorded. CONCLUSIONS: It should be kept in mind that cases of placenta previa and/or placenta accreta with previous cesarean sections have a very high probability of EPH. The delivery should be performed in suitable clinical settings with experienced surgeons when the risk factors like placenta previa and/or placenta accreta are determined so as to achieve optimal outcome.


Subject(s)
Delivery, Obstetric/statistics & numerical data , Hysterectomy/statistics & numerical data , Obstetric Labor Complications/surgery , Peripartum Period , Adult , Cesarean Section/statistics & numerical data , Emergencies , Female , Humans , Hysterectomy/adverse effects , Hysterectomy/mortality , Incidence , Infant Mortality , Infant, Newborn , Maternal Mortality , Obstetric Labor Complications/mortality , Placenta Accreta/surgery , Placenta Previa/surgery , Pregnancy , Retrospective Studies , Risk Factors , Stillbirth , Turkey/epidemiology , Uterine Inertia/surgery , Uterine Rupture/surgery , Young Adult
14.
Eur J Obstet Gynecol Reprod Biol ; 163(1): 71-5, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22480413

ABSTRACT

OBJECTIVE: To evaluate the efficacy of tertiary cytoreduction (TCR) on survival and to determine prognostic factors which may influence surgical and survival outcome. STUDY DESIGN: Twenty-three consecutive patients who had recurrent platinum-sensitive epithelial ovarian cancer and underwent TCR between January 1999 and January 2011 were evaluated. Factors which impact on TCR outcome and survival were determined by statistical analysis. RESULTS: TCR was optimal (< 1cm residual tumor) in 15 of the 23 patients (65.2%) and suboptimal in 8 patients (34.8%). None of the clinicopathologic factors was associated with TCR outcome. On the contrary, TCR outcome (optimal vs suboptimal) was independently associated with survival in univariate analysis (P=0.018). CONCLUSION: There is not a good predictor of TCR outcome but TCR seems to be beneficial for patients in whom optimal surgery can be achieved. Therefore, preoperative assessment of patients and weighing the potential survival benefit against potential surgical risks are very important for patient selection.


Subject(s)
Neoplasm Recurrence, Local/mortality , Neoplasms, Glandular and Epithelial/surgery , Ovarian Neoplasms/surgery , Platinum/therapeutic use , Adult , Aged , Carcinoma, Ovarian Epithelial , Female , Humans , Middle Aged , Neoplasm Recurrence, Local/surgery , Neoplasm, Residual , Neoplasms, Glandular and Epithelial/mortality , Ovarian Neoplasms/mortality , Prognosis , Retrospective Studies , Survival Analysis , Treatment Outcome
15.
Fertil Steril ; 95(2): 492-6, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20883991

ABSTRACT

OBJECTIVE: To compare efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS; Mirena) with depot GnRH analogue (GnRH-a; gosareline acetate; Zoladex) on endometriosis-related chronic pelvic pain (CPP) in patients with severe endometriosis during 12 months. DESIGN: Prospective, randomized, controlled study. SETTING: The reproductive endocrinology unit of a tertiary, research and education hospital. PATIENT(S): Forty women with severe endometriosis (revised The American Fertility Society [AFS] classification >40) and endometriosis-related CPP and control groups were enrolled in the study. INTERVENTION(S): The patients were treated with either LNG-IUS (n = 20) or GnRH-a (n = 20). The GnRH-a dose was repeated every 4 weeks for 24 weeks. MAIN OUTCOME MEASURE(S): Scores of CPP were evaluated using a visual analogue scale (VAS) and total endometriosis severity profile (TESP). RESULT(S): The TESP score decreased in the LNG-IUS group at first, third, and sixth month follow-up visits, whereas at the 12th month follow-up visit, the TESP scores were increased to values similar to pretreatment values. Although the VAS score had no significant alteration during the follow-up period in the LNG-IUS group, the GnRH-a group showed a significant decrease in the VAS score and TESP score at the end of 1 year. The LNG-IUS treatment showed a lower patient satisfaction. CONCLUSION(S): Both treatment modalities showed comparable effectiveness in the treatment of CPP-related endometriosis.


Subject(s)
Endometriosis/surgery , Goserelin/administration & dosage , Intrauterine Devices, Medicated , Levonorgestrel/administration & dosage , Pain, Postoperative/drug therapy , Pelvic Pain/drug therapy , Uterine Diseases/surgery , Adult , Chronic Disease , Delayed-Action Preparations , Endometriosis/complications , Endometriosis/drug therapy , Female , Fertility Agents, Female/administration & dosage , Follow-Up Studies , Gonadotropin-Releasing Hormone/administration & dosage , Gonadotropin-Releasing Hormone/adverse effects , Gonadotropin-Releasing Hormone/analogs & derivatives , Gynecologic Surgical Procedures/adverse effects , Gynecologic Surgical Procedures/rehabilitation , Humans , Intrauterine Devices, Medicated/adverse effects , Levonorgestrel/adverse effects , Pelvic Pain/etiology , Treatment Outcome , Uterine Diseases/complications , Uterine Diseases/drug therapy
16.
J Clin Ultrasound ; 38(6): 325-7, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20544870

ABSTRACT

We report a case of ovarian cystic teratoma with an important growth during pregnancy and the sonographic appearance of intracystic multiple, mobile, polygonal structures called intracystic "fat balls." Due to the rapid growth of the lesion, which exceeded 15 cm in diameter, a right oophorectomy was performed. Histopathologic diagnosis confirmed the mature cystic teratoma. The presence of floating balls composed of keratin and fat is rarely seen but is pathognomonic of mature cystic teratomas. Growth of a teratoma during pregnancy is a rare condition.


Subject(s)
Adipose Tissue/diagnostic imaging , Ovarian Neoplasms/diagnostic imaging , Teratoma/diagnostic imaging , Adipose Tissue/surgery , Adolescent , Female , Follow-Up Studies , Humans , Ovarian Neoplasms/surgery , Ovary/diagnostic imaging , Ovary/surgery , Pregnancy , Teratoma/surgery , Ultrasonography
17.
Arch Gynecol Obstet ; 282(6): 613-6, 2010 Dec.
Article in English | MEDLINE | ID: mdl-19856183

ABSTRACT

INTRODUCTION: Patients with history of gestational diabetes (GDM) are at high risk for developing diabetes mellitus (DM) after pregnancy. This study investigates the rate of GDM patients who received screening and the prevalence of DM in the early post-partum period. MATERIALS AND METHODS: This study included 78 patients diagnosed and treated for GDM between January 2005 and December 2007. They were evaluated whether or not they were screened with 75 g oral glucose tolerance test (OGTT) or fasting blood glucose measurement at post-partum 6-12-week period. The rates of DM and impaired glucose tolerance (IGT) were determined. RESULTS: Of 78 GDM patients only 10 (12.8%) patients were screened with OGTT and 27 (34.6%) patients were screened with fasting blood glucose (FBG) measurement. 41 (52.6%) patients did not receive any post-partum screening. Insulin treated patients during pregnancy underwent OGTT more frequently (p = 0.008). We found that 61% of the patients who did not receive any screening test were seen by a doctor for any reason during this period. DM was diagnosed in 50% of patients who underwent OGTT and 7.4% of patients who underwent FBG measurement during early post-partum period (p = 0.013). CONCLUSION: Despite the fact that GDM is generally strictly and carefully monitored during pregnancy, it is usually neglected in the post-partum period. Insulin treated patients during pregnancy should be informed better for post-partum screening with OGTT. OGTT appears to be a better way of screening to diagnose DM.


Subject(s)
Diabetes Mellitus/diagnosis , Mass Screening/statistics & numerical data , Postpartum Period , Adult , Diabetes, Gestational , Female , Glucose Tolerance Test/statistics & numerical data , Humans , Pregnancy , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...